<DOC>
	<DOCNO>NCT00392717</DOCNO>
	<brief_summary>Visceral obesity strongly associate dyslipidaemia ( hypertriglyceridaemia , low HDL-cholesterol mildly elevate LDL-cholesterol ) insulin resistance , key characteristic metabolic syndrome ( MetS ) . Recent evidence clearly establish risk CVD increase subject MetS . The precise reason remain unclear , appear closely related dyslipidaemia . Effective management dyslipidaemia important reduce risk CVD subject . Hypothesis : Inhibition hepatic cholesterol synthesis statin triglyceride synthesis fish oil improve lipoprotein metabolism visceral obese men .</brief_summary>
	<brief_title>Regulation Lipoprotein Metabolism Obese Men</brief_title>
	<detailed_description>The study employ factorial study design , stable isotopy mathematical modelling examine independent combine effect decrease cholesterol substrate availability atorvastatin decrease triglyceride substrate availability fish oil lipoprotien kinetics ( apoB , apoA , apoC-III chylomicron remnant ) insulin-resistant men visceral obesity .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Obesity define waist circumference &gt; 100 cm , waist : hip ratio &gt; 0.97 BMI &gt; 29 kg/m2 . Subjects select insulinresistance , define homostasis model assessment ( HOMA ) score ( 21 ) &gt; 5.1 ( i.e . one SD mean reference population 22 lean , normolipidemic healthy male similar age ) . All subject plasma triglyceride &gt; 1.2 mmol/L cholesterol &gt; 5.2 mmol/L screen consume ad libitum , weightmaintaining diet diabetes mellitus , apolipoprotein E2/E2 genotype , macroproteinuria , creatinemia , hypothyrodism , abnormal liver enzyme . Subjects consume fish oil supplement drink 30g alcohol/day . None report history CVD , take medication agent know affect lipid metabolism .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>lipoprotein metabolism</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>obesity</keyword>
</DOC>